Medicare Enrolled

Dr. Jillian Foglesong Stabile, M.D.

Family Medicine · Deer Park, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
905 EAST D STREET, Deer Park, WA 99006
5092765005
In practice since 2008 (18 years)
NPI: 1518134964 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Foglesong Stabile from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Foglesong Stabile? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Foglesong Stabile

Dr. Jillian Foglesong Stabile is a family medicine specialist in Deer Park, WA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Foglesong Stabile performed 11 Medicare services across 11 unique beneficiaries.

Between the years covered by Open Payments, Dr. Foglesong Stabile received a total of $2,013 from 32 pharmaceutical and/or device companies across 120 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Foglesong Stabile is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 11 Medicare services $2,013 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11
Medicare services
11
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
11 $2 $16
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,013
Total received (2018-2024)
Avg $288/year across 7 years
Top 10% in WA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
120
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,963 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$50 (2.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$496
2023
$358
2022
$198
2021
$68
2020
$175
2019
$247
2018
$471

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$147
Novo Nordisk Inc
$73
GlaxoSmithKline, LLC.
$70
PFIZER INC.
$57
Exact Sciences Corporation
$26
Merck Sharp & Dohme LLC
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Collegium Pharmaceutical, Inc.
$20
Phathom Pharmaceuticals, Inc.
$19
Neurocrine Biosciences, Inc.
$17
Xeris Pharmaceuticals, Inc.
$17
Top 3 companies account for 58.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$302
Astellas Pharma US Inc
$282
GlaxoSmithKline, LLC.
$222
PFIZER INC.
$140
Lilly USA, LLC
$105
Novartis Pharmaceuticals Corporation
$104
SANOFI PASTEUR INC.
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
AstraZeneca Pharmaceuticals LP
$58
Merck Sharp & Dohme LLC
$52
Janssen Pharmaceuticals, Inc
$51
Nevro Corp.
$51
Becton, Dickinson and Company
$50
Amgen Inc.
$46
Collegium Pharmaceutical, Inc.
$34
Sunovion Pharmaceuticals Inc.
$34
SI-BONE, Inc.
$32
Phadia US Inc.
$29
Ultragenyx Pharmaceutical Inc.
$27
Exact Sciences Corporation
$26
Corcept Therapeutics
$22
Philips Electronics North America Corporation
$20
ABBVIE INC.
$20
Phathom Pharmaceuticals, Inc.
$19
Merck Sharp & Dohme Corporation
$17
Neurocrine Biosciences, Inc.
$17
Xeris Pharmaceuticals, Inc.
$17
Braemar Manufacturing, LLC
$16
Mylan Specialty L.P.
$16
SANOFI-AVENTIS U.S. LLC
$13
Teva Pharmaceuticals USA, Inc.
$12
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$11
Top 3 companies account for 40.0% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AIMOVIG · AJOVY · ANORO · Aimovig · BD SafetyGlide · BEXSERO · BREO · BREZTRI AEROSPHERE · Belbuca · Cardiac Monitoring Suite · Cologuard Collection Kit · Crysvita · EMGALITY · ENTRESTO · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · GARDASIL · GVOKE HYPOPEN · INGREZZA · ImmunoCAP · JARDIANCE · Korlym · LONHALA MAGNAIR · MENQUADFI · MYRBETRIQ · Myrbetriq · NEXPLANON · NURTEC ODT · Ozempic · PAXLOVID · PREVNAR 13 · PREVNAR 20 · Perforomist · ROTATEQ · Rybelsus · SHINGRIX · SPRAVATO · STIOLTO · STIOLTO RESPIMAT · Senza · Senza Spinal Cord Stimulation System · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · VOQUEZNA · VRAYLAR · Veozah · Victoza · Wellcentive Undiv · XIFAXAN · XTAMPZA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for family medicine in WA.

Looking for a family medicine specialist in Deer Park?
Compare family medicine physicians in the Deer Park area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
326
Per 100K population
59.9
County median income
$73,513
Nearest hospital
PROVIDENCE HOLY FAMILY HOSPITAL
11.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Foglesong Stabile is a mixed practice specialist, with low-engagement industry engagement in the top 10% of WA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Foglesong Stabile experienced with automated urinalysis?
Based on Medicare claims data, Dr. Foglesong Stabile performed 11 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Foglesong Stabile receive payments from pharmaceutical companies?
Yes. Dr. Foglesong Stabile received a total of $2,013 from 32 companies across 120 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Foglesong Stabile's costs compare to other family medicine physicians in Deer Park?
Dr. Foglesong Stabile's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Foglesong Stabile) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →